Outlaw Laboratory, LP v. DG in PB, LLC

District Court, S.D. California·Decided June 17, 2020·No. 3:18-cv-00840·Unknown

Opinion

IN RE: OUTLAW LABORATORIES, LP Case No.: 18CV840 GPC (BGS) LITIGATION, ORDER ON JOINT STATEMENT . REGARDING FOUR OUTLAW DOCUMENTS

[ECF 214] Plaintiff Outlaw Laboratories, LP (“Outlaw”) and Counter-claimant Roma Mikha and Third-Party Plaintiff NMRM, Inc. and Skyline Market, Inc. (collectively the “Stores”) filed a Joint Statement on May 29, 2020 regarding four documents Outlaw claims are protected from disclosure by attorney-client privilege and the work product doctrine. (ECF 214.) The Joint Statement follows the parties’ submission of a joint letter brief to the Court with the four documents attached for in camera review. Outlaw claims the documents are privileged and should not be disclosed. The Stores argue the documents are not subject to attorney client privilege or the work product doctrine and argues even if they are, they are subject to the crime-fraud exception. The parties’ Joint Statement indicates “[t]he Stores and Outlaw agree that in camera review of the disputed documents is appropriate for resolving this dispute” and that “the documents were submitted by email to Judge Skomal’s Chambers on May 11, 2020. (Joint Statement [ECF 214] at 5.1) A. Claims in Consolidated Action This consolidated action encompasses two cases brought by Outlaw against retail stores for false advertising under the Lanham Act and as to the SD Outlet action, California False Advertising and California Unfair Competition claims. (Case Nos. 18cv840 (“DG in PB”) and 18cv1882 (“SD Outlet”); ECF 1472 at 4-5.). Three of the stores in the SD Outlet action have filed counterclaims as a class action on behalf of themselves and other targeted stores against Outlaw and additional parties under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) along with a rescission claim. (“Second Amended Counter Claims (“SACC”) [ECF 114].) The Court very briefly summarizes the claims below. Outlaw’s Lanham Act claims are premised on the defendants selling “male- enhancement pills, . . . ‘the Enhancement Products’” with packaging that indicate they are all natural, but contain undisclosed drugs with Outlaw claiming it has lost out on sales to those products. (ECF 147 at 1, 3-6; ECF 209 (San Diego Outlet action.) Summary Judgment was granted to defendants in the DG in PB action on this claim. (ECF 147.) The court found the defendant stores could not be found liable for false advertising for information on the packaging of the products they only sold. (Id. at 9-12.) As to the San Diego Outlet action, Judge Curiel recently granted a motion for judgment on the pleadings dismissing with prejudice on almost all of Outlaw’s claims. (ECF 209.) 1 All citations to the Joint Statement are to the CM/ECF electronic pagination. 2 In summarizing Outlaw’s claims and their status, the Court draws from Judge Curiel’s December 3, 2019 Order granting summary judgment to defendants in the DG in PB action and his May 29, 2020 Order granting in part defendants’ motion for judgment on Judgment on the pleadings was granted on the Lanham Act claim as to both direct and contributary liability as well as its California’s False Advertising Law (“FAL”) claim and the fraudulent and unlawful prongs of Outlaw’s California Unfair Competition Claim (“UCL”) claim. Only the unfairness prong of the UCL survived. (ECF 209 at 24-26.3) The Stores have alleged counterclaims under RICO on behalf of a class of similarly situated stores. (ECF 114.) The Stores allege that since at least December 2017, Outlaw, Outlaw’s former attorneys Tauler Smith, and Outlaw’s principles, Michael Wear and Shawn Lynch, have engaged in a scheme that includes sending demand letters via U.S. mail to small businesses that threaten the store could be held liable for over $100,000 based on false and misleading statements about potential liability for the sale of certain products by the stores. (SACC ¶¶ 2, 26, 82-88.) The SACC alleges Outlaw employs “investigators,” some hired through craigslist postings by Outlaw’s counsel Tauler Smith, who identify stores selling the products, take pictures of storefronts and shelves in the store with the products and provide that information to others participating in the scheme to target these stores. (SACC ¶¶ 66, 73, 86, 92.) The SACC alleges that Outlaw and its attorneys then send the demand letters, with FDA notice attached, that falsely indicate the store is illegally selling products in violation of RICO and the Lanham Act. (SACC ¶¶ 2, 23-24, 26-52, 84-86, 88.) The demand letters also allegedly include pictures taken of receipts for purchase of the products by investigators. (SACC ¶¶ 68, 73, 91.) The Stores allege the draft Complaint attached to the demand letters also falsely asserts that Outlaw sells a competitive product, the TriSteel products, in retail stores throughout the United States when it has never sold its products in stores and only started selling it online in October 2017. (SACC ¶¶ 66-67.) This commencement of any sales was months after Outlaw had already been documenting sales of the Enhancement Products by stores through investigators in August 2017. (SACC ¶ 68.) Outlaw then follows up with offers to settle for increasingly lower amounts, including as low as $2,500. (SACC ¶¶ 3-4, 56, 72, 87, 98.) B. The Stores Submissions in Support of Crime Fraud Exception To support their claim that these four documents are subject to the crime-fraud exception, the Stores rely on portions of the SACC that describe demand letters sent to stores with photos, taken by investigators, of receipts dated August 1, 2, and 4, 2017. (Joint Motion at 12 (citing SACC ¶ 68).4) The Stores argue this is significant because it shows Outlaw was targeting stores before Outlaw’s TriSteel product was even being sold.5 (Id.) The Stores cite a google index to show TriSteel was not sold online until October 17, 2017 and a spreadsheet produced in discovery by Outlaw. (Id. (citing SACC ¶ 67); Poe Decl., Ex. A (spreadsheet).) The Stores describe the spreadsheet as showing funding from the Pulaski Law Firm for the scheme as early as July 2017, months before Outlaw’s product was ever sold. (Joint Statement at 12.) The spreadsheet lists JST Distribution, not Outlaw, but as the Stores explain, Outlaw’s response to an interrogatory explains that “JST Distribution was an entity that was going to pursue litigation along with Outlaw,” initially paying “for investigators to collect evidence.” (Poe Decl., Ex. B.) The response also explains that Outlaw obtained the information gathered by JST Distribution after it pulled out of the litigation. (Id.) In further support of the connection between JST Distribution and Outlaw, the Stores provide a link to a news story in which Mr. Tauler of Tauler Smith apparently 4 The Stores reference Outlaw’s operative complaint being supported by “the Enterprise’s own documents” with citation to the SACC at ¶ 68. Although these documents were not submitted in support of this motion, they are in the record. The three attachments to demand letters show receipts of purchases by investigators in early August 2017. (ECF 90-21 [Ex. Q to the Stores’ Motion for Summary Judgment] at 9 (Midway Spirits – 8/2/2017), 74 (New Way Liquor – 8/1/2017), 108 (Main Street Liquor – 8/4/2017).) 5 As explained below, Outlaw has admitted that its products were never sold in retail admitted in correspondence that Outlaw and JST agreed that Outlaw would carry on the claims of JST Distribution. (Joint Statement at 13.6) They also explain that “[t]he website for JST Distribution’s litigation vehicle (a purported product called ‘Powerful Desire’) www.powerfuldesire.com redirects to www.tfsupplements.com whose initial registered agent was Outlaw’s owner and third-party defendant Mr. Wear, and which shares the same 6666 Gulf Freeway address as Outlaw Laboratory itself.” (Joint Statement at 13 (citing SACC ¶ 71.a).) Additionally, the Stores represent that in response to a Request for Admission Outlaw admitted that “Tri-Stee

Free access — add to your briefcase to read the full text and ask questions with AI

Outlaw Laboratory, LP v. DG in PB, LLC, (S.D. Cal. 2020).

Outlaw Laboratory, LP v. DG in PB, LLC (Outlaw Laboratory, LP v. DG in PB, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Mohawk Industries, Inc. v. Carpenter
558 U.S. 100 (Supreme Court, 2009)
United States v. Zolin
491 U.S. 554 (Supreme Court, 1989)
Bridge v. Phoenix Bond & Indemnity Co.
553 U.S. 639 (Supreme Court, 2008)
Omar, Sandra K. v. Harvey, Francis J.
479 F.3d 1 (D.C. Circuit, 2007)
United States v. Jerry R. Bohonus
628 F.2d 1167 (Ninth Circuit, 1980)
In Re Napster, Inc. Copyright Litigation
479 F.3d 1078 (Ninth Circuit, 2007)
Kismet Acquisition v. Alejandro Diaz-Barba
755 F.3d 1130 (Ninth Circuit, 2014)
In re Outlaw Labs., LP Litig.
352 F. Supp. 3d 992 (S.D. California, 2018)
United States v. Doe & Corp.
810 F.3d 1110 (Ninth Circuit, 2016)
Laser Industries, Ltd. v. Reliant Technologies, Inc.
167 F.R.D. 417 (N.D. California, 1996)
United States v. Hodge & Zweig
548 F.2d 1347 (Ninth Circuit, 1977)